CompletedNot Applicable

Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes

United States20 participantsStarted 2024-01-29

Plain-language summary

Use of continuous glucose monitor (CGM) in post kidney transplant patients to better assess changes in glucose levels post kidney transplant

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Time in Range (TIR)

Timeframe: 6 months

Hospital Readmission

Timeframe: 6 months

Time below range (TBR)

Timeframe: 6 months

Time above range (TAR)

Timeframe: 6 months

Rejection

Timeframe: 6 months

Delayed graft function

Timeframe: 6 months

NCT IDNCT07271433

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-12